Jaguar Health, Inc. insider trading

Every open-market purchase and sale by Jaguar Health, Inc.'s officers, directors and largest shareholders since November 4, 2021, and what the share price did next.

No open-market insider trades reported in the last five years.

Does following Jaguar Health, Inc.’s insiders pay?

From February 9, 2016 to March 30, 2022, 5 insiders reported 8 open-market purchases and 1 sale not made under a pre-set plan in Jaguar Health, Inc.

Jaguar Health, Inc.: each insider's record
Insider	Role	Purchases	12 months after their purchases	Beat the S&P 500	Sales	12 months after their sales	Latest report
Bochnowski James J	Director	3	—	—	0	—	July 25, 2019
Siegel Jonathan B.	Director	3	—	—	0	—	July 25, 2019
Conte Lisa A	CEO and President	1	—	—	0	—	March 30, 2022
Lizak Carol R.	Chief Financial Officer	1	—	—	0	—	March 30, 2022
Nantucket Investments Ltd	10% owner	0	—	—	1	—	October 24, 2018

Moves are the shares’ return including dividends minus the S&P 500’s, from the close on the first trading day after each report; the number of trades with a finished 12-month window is in brackets. Green means the trade went the insider’s way (a purchase ahead of the index, a sale followed by the shares trailing it). A trade reported both by a director or officer and by a fund or company they are linked to counts once here, under the person. Purchases count only where the share price actually traded was at least $5. These figures describe what the shares did, not why anyone traded. Insiders across all companies.

← Back to Jaguar Health, Inc. · Funds · Politicians